| Drug Type Autologous CAR-T | 
| Synonyms | 
| Target | 
| Action inhibitors | 
| Mechanism EBV Protein inhibitors | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhasePreclinical | 
| First Approval Date- | 
| Regulation- | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Nasopharyngeal Carcinoma | Preclinical | China  | 30 Jan 2022 | |
| Nasopharyngeal Neoplasms | Preclinical | - | - | 





